Potentia Wealth Takes Position in Oscar Health, Inc. (NYSE:OSCR)

Potentia Wealth purchased a new position in shares of Oscar Health, Inc. (NYSE:OSCR) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 10,509 shares of the company’s stock, valued at approximately $141,000.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Arizona State Retirement System boosted its stake in shares of Oscar Health by 3.1% during the fourth quarter. Arizona State Retirement System now owns 47,918 shares of the company’s stock worth $644,000 after buying an additional 1,454 shares during the period. Xponance Inc. lifted its position in Oscar Health by 12.9% during the 4th quarter. Xponance Inc. now owns 14,394 shares of the company’s stock worth $193,000 after acquiring an additional 1,649 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Oscar Health by 9.2% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 26,446 shares of the company’s stock valued at $561,000 after purchasing an additional 2,236 shares during the last quarter. KBC Group NV increased its holdings in shares of Oscar Health by 56.1% in the fourth quarter. KBC Group NV now owns 7,107 shares of the company’s stock valued at $96,000 after purchasing an additional 2,555 shares during the period. Finally, PNC Financial Services Group Inc. raised its stake in shares of Oscar Health by 20.5% during the fourth quarter. PNC Financial Services Group Inc. now owns 17,896 shares of the company’s stock worth $241,000 after purchasing an additional 3,040 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on OSCR shares. Jefferies Financial Group assumed coverage on shares of Oscar Health in a research report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 price objective on the stock. Wells Fargo & Company lowered shares of Oscar Health from an “overweight” rating to an “equal weight” rating and dropped their price target for the stock from $20.00 to $16.00 in a research note on Thursday, March 13th. Two analysts have rated the stock with a sell rating, three have given a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $20.21.

Oscar Health Stock Up 7.3 %

OSCR stock opened at $14.00 on Tuesday. Oscar Health, Inc. has a 52 week low of $12.43 and a 52 week high of $23.79. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The company has a market cap of $3.51 billion, a P/E ratio of -699.40 and a beta of 1.75. The company’s 50-day moving average price is $15.03 and its 200 day moving average price is $16.18.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. On average, research analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.